期刊文献+

MDM2-p53抑制剂nutlin-3对野生型p53肿瘤细胞系的抑制作用及机制的研究

The inhibitory effect and mechanism of MDM2-p53 inhibitor nutlin-3 on wild-type p53 tumor cell lines
原文传递
导出
摘要 Nutlin-3是代表性小分子MDM2-p53拮抗剂,能通过破坏p53和MDM2的相互作用,稳定p53状态,从而诱导p53信号通路发挥抗肿瘤作用。本研究以HCT-116、H460、HepG2、MCF-7、A549、SJSA-1六种野生型p53肿瘤细胞系为研究对象,采用噻唑蓝(methyl thiazolyl tetrazolium,MTT)法、平板克隆实验检测nutlin-3对6种不同野生型p53癌细胞增殖的影响;通过流式细胞术检测nutlin-3对H460细胞周期和细胞凋亡的影响;通过蛋白印迹实验检测泛素特异蛋白酶7(ubiquitin-specific protease 7,USP7)、细胞死亡结构域相关蛋白(death domain-associated protein,DAXX)、鼠双微体2(murine double minute 2,MDM2)、鼠双微体4(murine double minute 4,MDMX/MDM4)、p53的表达,探讨nutlin-3的抗肿瘤作用机制;通过免疫共沉淀(co-immunoprecipitation,Co-IP)实验检测nutlin-3对MDM2与MDMX、p53相互作用的影响。结果显示,nutlin-3呈时间和浓度依赖性地抑制H460的增殖;细胞周期和凋亡结果显示,nutlin-3能阻滞H460细胞周期于G0/G1期,通过激活cleaved-PARP并诱导细胞凋亡;蛋白印迹结果显示,nutlin-3能够上调H460细胞中USP7、DAXX、MDM2、MDMX、p53蛋白的表达;Co-IP结果表明,nutlin-3抑制MDM2与p53、MDM2与MDMX的蛋白相互作用。综上所述,nutlin-3能够显著抑制野生型p53癌细胞的增殖,并诱导细胞周期阻滞和细胞凋亡,其机制可能与破坏MDM2/MDMX与p53相互作用,从而激活MDM2-p53信号通路有关。 Nutlin-3 is a representative small molecule MDM2-p53 antagonist,which can stabilize the p53 state by disrupting the interaction between p53 and MDM2,thereby inducing the p53 signaling pathway to exert antitumor effects.In this study,six wild-type p53 tumor cell lines,HCT-116,H460,HepG2,MCF-7,A549 and SJSA-1,were used as research objects,and the effects of nutlin-3 on the proliferation of six wild-type p53 cancer cells were detected by methyl thiazolyl tetrazolium(MTT)method and plate cloning assay.The effects of nutlin-3 on H460 cell cycle and apoptosis were detected by flow cytometry.Western blot assay was used to detect ubiquitinspecific protease 7(USP7),death domain-associated protein(DAXX),murine double minute 2(MDM2),murine double minute 4(MDMX/MDM4),p53,to explore the anti-tumor mechanism of nutlin-3;co-immunoprecipitation(Co-IP)assay was used to detect the effect of nutlin-3 on the interaction between MDM2,MDMX and p53.The results showed that nutlin-3 inhibited the proliferation of H460 in a time-and concentration-dependent manner.The results of cell cycle and apoptosis showed that nutlin-3 could block the H460 cell cycle in the G0/G1 phase,and induce apoptosis by activating cleaved-PARP.Western blot results showed that nutlin-3 could up-regulate the expression of USP7,DAXX,MDM2,MDMX and p53 in H460 cells.Co-IP results showed that nutlin-3 inhibited the protein interactions between MDM2 and p53 and MDM2 and MDMX.In conclusion,nutlin-3 can significantly inhibit the proliferation of wild-type p53 cancer cells and induce cell cycle arrest and apoptosis,which may be related to the disruption of MDM2/MDMX's interaction with p53 to activate the MDM2-p53 signaling pathway.
作者 马明远 刘莹莹 钱宇卿 周思雨 李铭东 MA Ming-yuan;LIU Ying-ying;QIAN Yu-qing;ZHOU Si-yu;LI Ming-dong(School of Pharmacy,Jiangxi University of Chinese Medicine,Nanchang 330006,China)
出处 《药学学报》 北大核心 2025年第5期1407-1413,共7页 Acta Pharmaceutica Sinica
基金 江西省教育厅科学技术研究项目(GJJ2400827,GJJ2400835)。
关键词 nutlin-3 MDM2-p53抑制剂 MDM2 野生型P53 抗肿瘤 nutlin-3 MDM2-p53 inhibitor MDM2 wild-type p53 anti-tumor
  • 相关文献

参考文献4

二级参考文献119

  • 1Cahilly-Snyder L, Yang-Feng T, Francke U and George DL. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet 1987, 13: 235-244.
  • 2Fakharzadeh SS, Trusko SP and George DL. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 1991, 10: 1565-1569.
  • 3Roth J, Dobbelstein M, Freedman DA, Shenk T and Levine AJ. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J 1998, 17: 554-564.
  • 4Zhang Y and Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009, 16: 369-377.
  • 5Lindstrom MS, Jin A, Deisenroth C, White Wolf G and Zhang Y. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol Cell Bioi 2007, 27: 1056-1068.
  • 6Boddy MN, Freemont PS and Borden KL. The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger. Trends Biochem Sci 1994, 19: 198-199.
  • 7Honda R, Tanaka H and Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressorp53. FEBS Lett 1997, 420: 25-27.
  • 8Poyurovsky MV, Priest C, Kentsis A, Borden KL, Pan ZQ, Pavletich N and Prives C. The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity. EMBO J 2007, 26: 90-101.
  • 9Thrower JS, Hoffman L, Rechsteiner M and Pickart CM. Recognition of the polyubiquitin proteolytic signal. EMBO J 2000, 19: 94-102.
  • 10Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997,88: 323-331.

共引文献1695

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部